You Searched For "adagio therapeutics stock price" and got 20 results
Sort By:
2 mins read
Adagio Therapeutics extends 3-day gain to 319% on hopes that its antiviral can treat the Omicron variant
"ADG20 was uniquely designed to combine breadth, potency and duration of protection against SARS-Co…
Matthew Fox
2 mins read
A surfer without a degree is worth $16 billion after his biotech company's stock soared 1,100% in a year
Bob Duggan, 80, has gone from baking cookies to building robots, investing in biotech companies, an…
Theron Mohamed
3 mins read
Glenmark to divest 75% stake in Glenmark Life Sciences to Nirma; stock slips
The Glenmark Pharmaceuticals stock was almost down 5% in Friday morning trade after the pharma maj…
2 mins read
Viking Therapeutics' weight loss drug showed faster results in clinical trials than Ozempic or Wegovy. Here's how it works.
Viking Therapeutics' experimental drug helped patients lose weight faster than other popular GLP-1 …
Gabby Landsverk
1 min read
This overlooked obesity-drug stock has 80% upside, JPMorgan says
JPMorgan said it expects Structure Therapeutics' oral GLP-1 weight loss drug candidate to generate …
Matthew Fox
1 min read
Obalon Therapeutics skyrockets 568% after announcing merger with weight-loss company ReShape Lifesciences
Trading volume for Obalon Therapeutics exploded on news it will merge with weight-loss company ReSh…
Emily Graffeo
2 mins read
Stocks held by ARK Invest's flagship innovation fund have seen huge losses. Here are the fund's 10 biggest losers.
The flagship ARKK ETF is holding onto three stocks that are down more than 90% since Cathie Wood's …
Matthew Fox
6 mins read
Mankind Pharma stock runs up in trade after listing at 20% premium
After listing at a 20% premium, condom manufacturer Mankind Pharma’s stock ran up 9.5% on Tuesday. …
2 mins read
Prevail Therapeutics surges 86% on news of a $1 billion buyout by Eli Lilly
Eli Lilly will pay $22.50 per share for Prevail, as well as an additional $4 per share that hinges …
Ben Winck
1 min read
Trillium Therapeutics soars 200% after Pfizer inks deal to buy cancer-drug company for $2.3 billion
Pfizer had originally invested $25 million in Trillium in September of last year, as part of its br…
Matthew Fox
2 mins read
Arcturus Therapeutics plummets 53% after analyst downgrades following COVID-19 vaccine trial updates
The Singapore Health Sciences Authority approved the Arcturus vaccine candidate for Phase 2 clinica…
Emily Graffeo
1 min read
Pandion Therapeutics soars 132% after Merck agrees to buy the biotech for $1.85 billion
Pandion is a clinical-stage biotechnology company that is developing therapeutics for patients livi…
Matthew Fox
1 min read
Intellia Therapeutics soars 63% after its gene-editing CRISPR therapy shows success in first human trials
Intellia partnered with Regeneron in 2016 to advance the CRISPR technology for in vivo therapeutic …
Matthew Fox
2 mins read
A Harvard medical professor is now a billionaire after his early stake in Moderna soared 17,000%
Timothy Springer invested $5 million in the biotech company early on, and his stake has since swell…
Ben Winck
4 mins read
Using video games as medical treatments seemed promising, but a stunning failure raises questions about the future of digital therapeutics
After Pear Therapeutics' bankruptcy, experts warn that more failures are coming for the digital-the…
Rebecca Torrence
1 min read
Granules India gets USFDA nod for generic drug used for short-term treatment of heartburn
Granules India Ltd on Thursday said it has received approval from the US health regulator for its g…
PTI
2 mins read
Pfizer and BioNTech surge after the FDA officially approves its COVID-19 vaccine
The vaccine will be marketed under the brand name Comirnaty, and the FDA hopes the approval will nu…
Matthew Fox
1 min read
Moderna spikes 11% to record highs after it is selected to be added to S&P 500
Alexion Therapeutics, which is set to be acquired by AstraZeneca, will be replaced by Moderna in th…
Matthew Fox
2 mins read
The 5 biggest insider stock buys of last week
Here are the five companies that saw the biggest combined stock purchases from insiders during the …
Isabelle Lee
1 min read
Aimmune Therapeutics soars 172% after Nestle agrees to acquire the peanut allergy treatment company for $2.6 billion
Nestle expects the acquisition to be accretive to its organic growth in 2021, and accretive to cash…